Evotec SE (EVO) Asset Writedowns and Impairment (2021)

Evotec SE (EVO) reported Asset Writedowns and Impairment of -$781.33 for Q4 2021, up 85.25% sequentially from -$5296.2 in Q3 2021.

Evotec SE (EVO) Asset Writedowns and Impairment (2021) Analysis & Trends

Evotec SE (EVO) has 1 years of Asset Writedowns and Impairment data on file, last reported at -$781.33 in Q4 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn
10	Evotec SE	351.60 Mn	351.08 Mn	-

Download Data